The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Agomelatine Tablets Market Research Report 2025
Synopsis
The global Agomelatine Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Agomelatine Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Agomelatine Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Agomelatine Tablets include Servier, Rovi Pharma, Novartis, Nectid and Jiangsu Haosen Pharmaceutical Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Agomelatine Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Agomelatine Tablets.
Report Scope
The Agomelatine Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Boxes) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Agomelatine Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Agomelatine Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Servier
Rovi Pharma
Novartis
Nectid
Jiangsu Haosen Pharmaceutical Group
Segment by Type
Serotonin 2C Agonist
Melatonin Receptor 2 Agonist
Melatonin Receptor 1 Agonist
Serotonin Receptor Agonist
Serotonin 2C Receptor Antagonist
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Agomelatine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Agomelatine Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Agomelatine Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Agomelatine Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Agomelatine Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Agomelatine Tablets include Servier, Rovi Pharma, Novartis, Nectid and Jiangsu Haosen Pharmaceutical Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Agomelatine Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Agomelatine Tablets.
Report Scope
The Agomelatine Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Boxes) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Agomelatine Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Agomelatine Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Servier
Rovi Pharma
Novartis
Nectid
Jiangsu Haosen Pharmaceutical Group
Segment by Type
Serotonin 2C Agonist
Melatonin Receptor 2 Agonist
Melatonin Receptor 1 Agonist
Serotonin Receptor Agonist
Serotonin 2C Receptor Antagonist
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Agomelatine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Agomelatine Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Agomelatine Tablets Market Overview
1.1 Product Overview and Scope of Agomelatine Tablets
1.2 Agomelatine Tablets Segment by Type
1.2.1 Global Agomelatine Tablets Market Value Comparison by Type (2024-2030)
1.2.2 Serotonin 2C Agonist
1.2.3 Melatonin Receptor 2 Agonist
1.2.4 Melatonin Receptor 1 Agonist
1.2.5 Serotonin Receptor Agonist
1.2.6 Serotonin 2C Receptor Antagonist
1.3 Agomelatine Tablets Segment by Application
1.3.1 Global Agomelatine Tablets Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Agomelatine Tablets Market Size Estimates and Forecasts
1.4.1 Global Agomelatine Tablets Revenue 2019-2030
1.4.2 Global Agomelatine Tablets Sales 2019-2030
1.4.3 Global Agomelatine Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Agomelatine Tablets Market Competition by Manufacturers
2.1 Global Agomelatine Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Agomelatine Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Agomelatine Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Agomelatine Tablets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Agomelatine Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Agomelatine Tablets, Product Type & Application
2.7 Agomelatine Tablets Market Competitive Situation and Trends
2.7.1 Agomelatine Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Agomelatine Tablets Players Market Share by Revenue
2.7.3 Global Agomelatine Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Agomelatine Tablets Retrospective Market Scenario by Region
3.1 Global Agomelatine Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Agomelatine Tablets Global Agomelatine Tablets Sales by Region: 2019-2030
3.2.1 Global Agomelatine Tablets Sales by Region: 2019-2024
3.2.2 Global Agomelatine Tablets Sales by Region: 2025-2030
3.3 Global Agomelatine Tablets Global Agomelatine Tablets Revenue by Region: 2019-2030
3.3.1 Global Agomelatine Tablets Revenue by Region: 2019-2024
3.3.2 Global Agomelatine Tablets Revenue by Region: 2025-2030
3.4 North America Agomelatine Tablets Market Facts & Figures by Country
3.4.1 North America Agomelatine Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Agomelatine Tablets Sales by Country (2019-2030)
3.4.3 North America Agomelatine Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Agomelatine Tablets Market Facts & Figures by Country
3.5.1 Europe Agomelatine Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Agomelatine Tablets Sales by Country (2019-2030)
3.5.3 Europe Agomelatine Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Agomelatine Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Agomelatine Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Agomelatine Tablets Sales by Country (2019-2030)
3.6.3 Asia Pacific Agomelatine Tablets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Agomelatine Tablets Market Facts & Figures by Country
3.7.1 Latin America Agomelatine Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Agomelatine Tablets Sales by Country (2019-2030)
3.7.3 Latin America Agomelatine Tablets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Agomelatine Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Agomelatine Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Agomelatine Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Agomelatine Tablets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Agomelatine Tablets Sales by Type (2019-2030)
4.1.1 Global Agomelatine Tablets Sales by Type (2019-2024)
4.1.2 Global Agomelatine Tablets Sales by Type (2025-2030)
4.1.3 Global Agomelatine Tablets Sales Market Share by Type (2019-2030)
4.2 Global Agomelatine Tablets Revenue by Type (2019-2030)
4.2.1 Global Agomelatine Tablets Revenue by Type (2019-2024)
4.2.2 Global Agomelatine Tablets Revenue by Type (2025-2030)
4.2.3 Global Agomelatine Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Agomelatine Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Agomelatine Tablets Sales by Application (2019-2030)
5.1.1 Global Agomelatine Tablets Sales by Application (2019-2024)
5.1.2 Global Agomelatine Tablets Sales by Application (2025-2030)
5.1.3 Global Agomelatine Tablets Sales Market Share by Application (2019-2030)
5.2 Global Agomelatine Tablets Revenue by Application (2019-2030)
5.2.1 Global Agomelatine Tablets Revenue by Application (2019-2024)
5.2.2 Global Agomelatine Tablets Revenue by Application (2025-2030)
5.2.3 Global Agomelatine Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Agomelatine Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Servier
6.1.1 Servier Corporation Information
6.1.2 Servier Description and Business Overview
6.1.3 Servier Agomelatine Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Servier Agomelatine Tablets Product Portfolio
6.1.5 Servier Recent Developments/Updates
6.2 Rovi Pharma
6.2.1 Rovi Pharma Corporation Information
6.2.2 Rovi Pharma Description and Business Overview
6.2.3 Rovi Pharma Agomelatine Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Rovi Pharma Agomelatine Tablets Product Portfolio
6.2.5 Rovi Pharma Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Agomelatine Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Agomelatine Tablets Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Nectid
6.4.1 Nectid Corporation Information
6.4.2 Nectid Description and Business Overview
6.4.3 Nectid Agomelatine Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nectid Agomelatine Tablets Product Portfolio
6.4.5 Nectid Recent Developments/Updates
6.5 Jiangsu Haosen Pharmaceutical Group
6.5.1 Jiangsu Haosen Pharmaceutical Group Corporation Information
6.5.2 Jiangsu Haosen Pharmaceutical Group Description and Business Overview
6.5.3 Jiangsu Haosen Pharmaceutical Group Agomelatine Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Jiangsu Haosen Pharmaceutical Group Agomelatine Tablets Product Portfolio
6.5.5 Jiangsu Haosen Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Agomelatine Tablets Industry Chain Analysis
7.2 Agomelatine Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Agomelatine Tablets Production Mode & Process
7.4 Agomelatine Tablets Sales and Marketing
7.4.1 Agomelatine Tablets Sales Channels
7.4.2 Agomelatine Tablets Distributors
7.5 Agomelatine Tablets Customers
8 Agomelatine Tablets Market Dynamics
8.1 Agomelatine Tablets Industry Trends
8.2 Agomelatine Tablets Market Drivers
8.3 Agomelatine Tablets Market Challenges
8.4 Agomelatine Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
